Altre lingue Hana Pharm Co., Ltd.

Azioni

A293480

KR7293480000

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 21/05/2024			Variaz. 5gg	Var. 1 gen.
13.010 ^KRW	-1,36%		-1,14%	-6,74%

2023	Le azioni di Singapore tornano al verde; Hyphens Pharma sale del 5% grazie all'accordo per lo sviluppo di un farmaco per la sedazione a Singapore	MT
2023	Hyphens Pharma svilupperà e commercializzerà il farmaco sedativo di Hana Pharm a Singapore	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore	18/05/23
Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore	18/05/23
Hyphens Pharma Pte. Ltd. Signs an Exclusive Sub-License and Supply Agreement with Hana Pharm Co., Ltd. to Develop and Commercialise Byfavo® 20mg in Singapore	17/05/23
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12/04/22
Hana Pharm Receives Market Approval for Byfavo (Remimazolam) in Procedural Sedation in South Korea	31/08/21
Hana Pharm Informs PAION AG About the Launch of Byfavo™ (Remimazolam) for the Use in General Anesthesia in South Korea	07/04/21
Hana Pharm Co., Ltd's Equity Buyback announced on August 19, 2019, has expired.	18/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.	05/02/20
Hana Pharm Co., Ltd's Equity Buyback announced on August 6, 2019, has expired with 87,239 shares, representing 0.54% for KRW 1,997.13 million.	05/02/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 9, 2019.	08/01/20
Hana Pharm Co., Ltd's Equity Buyback announced on July 9, 2019, has expired.	08/01/20
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 26, 2019.	30/10/19
Hana Pharm Co., Ltd's Equity Buyback announced on July 26, 2019, has expired with 84,312 shares, representing 0.53% for KRW 1,997.08 million.	30/10/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	19/08/19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	19/08/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06/08/19
Hana Pharm Co., Ltd authorizes a Buyback Plan.	06/08/19
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	26/07/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hana Pharm Co., Ltd.

Azioni

A293480

KR7293480000

Altre lingue

Filtri